Oxford Biomedica plc (LON:OXB)
London · Delayed Price · Currency is GBP · Price in GBX 487.00
-0.50 (-0.10%)
Aug 14, 2026, 5:07 PM GMT
Oxford Biomedica Market Cap
Oxford Biomedica has a market cap or net worth of 589.46 million as of August 14, 2026. Its market cap has increased by 25.01% in one year.
Market Cap
589.46M
Enterprise Value
640.68M
Revenue
168.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
487.00
ChartMarket Cap Chart
Since September 22, 1997, Oxford Biomedica's market cap has increased from 17.39M to 589.46M, an increase of 3,288.91%. That is a compound annual growth rate of 12.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 589.46M | -20.74% |
| Dec 31, 2025 | 743.72M | 67.15% |
| Dec 31, 2024 | 444.94M | 108.92% |
| Dec 29, 2023 | 212.97M | -50.00% |
| Dec 30, 2022 | 425.96M | -59.79% |
| Dec 31, 2021 | 1.06B | 24.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genus | 1.51B |
| Oxford Nanopore Technologies | 1.24B |
| Avacta Group | 302.12M |
| PureTech Health | 297.94M |
| Scancell Holdings | 116.37M |
| Faron Pharmaceuticals Oy | 91.98M |
| 4basebio | 85.46M |
| Bioventix | 78.37M |